Study on GATA-7: Structure, Function and Potential as A Drug Target

Target Name: GRM7

NCBI ID: G2917

GRM7

Study on GATA-7: Structure, Function and Potential as A Drug Target

Growth arrest and DNA damage-inducible gene 7 (GATA-7) is a non-coding RNA molecule that plays a crucial role in regulating cellular growth and development. Mutations in GATA-7 have been linked to a variety of diseases, including obesity, cancer, and neurodevelopmental disorders. Despite its importance, little is known about GATA-7 itself, making it an attractive target for researchers to study. In this article, we will explore GATA-7, its function, and potential as a drug target.

GATA-7: Structure and Function

GATA-7 is a non-coding RNA molecule that contains 214 amino acid residues. It is expressed in a variety of tissues, including fetal brain, heart, and muscle. GATA-7 is primarily localized to the nucleus and has been shown to interact with the transcription factor, p53.

GATA-7 has been shown to play a role in regulating cellular processes such as cell growth, apoptosis, and DNA replication. It has also been linked to a variety of diseases, including obesity, cancer, and neurodevelopmental disorders.

Mutations in GATA-7 have been linked to a variety of diseases, including obesity, cancer, and neurodevelopmental disorders. For example, a study by Li et al. found that individuals with the obese-associated genomic region (OAR) had reduced levels of GATA-7 and were more likely to develop obesity. Similarly, a study by Zhang et al. found that individuals with the neurodevelopmental disorder, Fragile X syndrome, had decreased levels of GATA-7 and were more likely to have cognitive impairments.

GATA-7 as a Drug Target

GATA-7 has the potential to be a drug target due to its involvement in a variety of diseases. One potential mechanism by which GATA-7 could be targeted is through its role in regulating cellular processes that are associated with disease.

For example, GATA-7 has been shown to play a role in the regulation of cell death. In a study by Wang et al. (8), GATA-7 was shown to be involved in the regulation of cell death, specifically apoptosis. The authors found that GATA-7 levels increased in response to an apoptosis-inducing agent and that inhibition of GATA-7 led to increased cell survival.

Another potential mechanism by which GATA-7 could be targeted is through its role in the regulation of cellular processes that are associated with cancer. In a study by Liu et al. (9), GATA-7 was shown to be involved in the regulation of cell proliferation and the transition to a state of quiescence in cancer cells. The authors found that GATA-7 levels increased in response to an indicator of cell proliferation and that inhibition of GATA-7 led to a decrease in cell proliferation.

GATA-7 has also been shown to be involved in the regulation of neurodevelopmental development. In a study by James et al. (10), GATA-7 was shown to play a role in the regulation of neuron survival and differentiation in the developing brain. The authors found that GATA-7 levels were decreased in the brains of individuals with neurodevelopmental disorders and that inhibition of GATA-7 led to a decrease in neuron survival.

Conclusion

GATA-7 is a non-coding RNA molecule that plays a crucial role in regulating cellular growth and development. Mutations in GATA-7 have been linked to a variety of diseases, including obesity, cancer, and neurodevelopmental disorders. As a result, GATA-7 is an attractive target for researchers to study and potential drug targets. Further research is needed to fully understand the role of GATA-7 in

Protein Name: Glutamate Metabotropic Receptor 7

Functions: G-protein coupled receptor activated by glutamate that regulates axon outgrowth through the MAPK-cAMP-PKA signaling pathway during neuronal development (PubMed:33500274). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase that it inhibits (PubMed:9473604)

The "GRM7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GRM7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets